Incontinence: Difference between revisions
| Line 16: | Line 16: | ||
*Urogenital fistula | *Urogenital fistula | ||
*Neurologic disorders | *Neurologic disorders | ||
*Medication toxicity | |||
*[[Constipation]] | *[[Constipation]] | ||
Revision as of 18:54, 12 December 2022
Background
- Defined as the involuntary leakage of urine
- Estimated prevalence of ~40% of women and ~21% of men older than 65 years of age[1][2]
- Can have profound impact on quality of life, sexual dysfunction, and morbidity (e.g., perineal infections, falls)
Clinical Features
- Three main classifications of incontinence: Stress, Urgency, Overflow
- Mixed urinary incontinence: Symptoms of both stress and urgency
Differential Diagnosis
- Vaginal atrophy
- Urinary tract infection
- Urogenital fistula
- Neurologic disorders
- Medication toxicity
- Constipation
Evaluation
Workup
Diagnosis
Management
Disposition
See Also
External Links
References
- ↑ Minassian VA, Yan X, Lichtenfeld MJ, Sun H, Stewart WF. The iceberg of health care utilization in women with urinary incontinence. Int Urogynecol J. 2012 Aug;23(8):1087-93. doi: 10.1007/s00192-012-1743-x. Epub 2012 Apr 12. PMID: 22527544; PMCID: PMC3905313.
- ↑ Shamliyan TA, Wyman JF, Ping R, Wilt TJ, Kane RL. Male urinary incontinence: prevalence, risk factors, and preventive interventions. Rev Urol. 2009 Summer;11(3):145-65. PMID: 19918340; PMCID: PMC2777062.
- ↑ Abrams P, Andersson KE, Birder L, Brubaker L, Cardozo L, Chapple C, Cottenden A, Davila W, de Ridder D, Dmochowski R, Drake M, Dubeau C, Fry C, Hanno P, Smith JH, Herschorn S, Hosker G, Kelleher C, Koelbl H, Khoury S, Madoff R, Milsom I, Moore K, Newman D, Nitti V, Norton C, Nygaard I, Payne C, Smith A, Staskin D, Tekgul S, Thuroff J, Tubaro A, Vodusek D, Wein A, Wyndaele JJ; Members of Committees; Fourth International Consultation on Incontinence. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn. 2010;29(1):213-40. doi: 10.1002/nau.20870. PMID: 20025020.
- ↑ Abrams P, Andersson KE, Birder L, Brubaker L, Cardozo L, Chapple C, Cottenden A, Davila W, de Ridder D, Dmochowski R, Drake M, Dubeau C, Fry C, Hanno P, Smith JH, Herschorn S, Hosker G, Kelleher C, Koelbl H, Khoury S, Madoff R, Milsom I, Moore K, Newman D, Nitti V, Norton C, Nygaard I, Payne C, Smith A, Staskin D, Tekgul S, Thuroff J, Tubaro A, Vodusek D, Wein A, Wyndaele JJ; Members of Committees; Fourth International Consultation on Incontinence. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn. 2010;29(1):213-40. doi: 10.1002/nau.20870. PMID: 20025020.